Evidence map›Paper›PMID 32509105›Full record

ArticleInternational journal of clinical and experimental pathology2020

Erratum: MiR-30a-5p suppresses cell growth and enhances apoptosis of hepatocellular carcinoma cells via targeting AEG-1.

Rongquan He, Lihua Yang, Xiaomiao Lin, Xin Chen, Xinggu Lin, Fanglin Wei, Xiaona Liang, Yihuan Luo, Yuzhuang Wu, Tingqing Gan and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC
In one paragraph

Article in International journal of clinical and experimental pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Rongquan HeDepartment of Medical Oncology, The First Affiliated Hospital of Guangxi Medical University Nanning, P. R. China.
Lihua YangDepartment of Medical Oncology, The First Affiliated Hospital of Guangxi Medical University Nanning, P. R. China.
Xiaomiao LinDepartment of Children Rehabilitation Medicine, Guangxi Maternal and Child Health Hospital Nanning, Guangxi Zhuang Autonomous Region, P. R. China.
Xin ChenDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University Nanning, P. R. China.
Xinggu LinKey Laboratory for Genomic and Personalized Medicine, Guangxi Medical University Nanning, P. R. China.
Fanglin WeiDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University Nanning, P. R. China.
Xiaona LiangDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University Nanning, P. R. China.
Yihuan LuoDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University Nanning, P. R. China.
Yuzhuang WuDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University Nanning, P. R. China.
Tingqing GanDepartment of Medical Oncology, The First Affiliated Hospital of Guangxi Medical University Nanning, P. R. China.
Yiwu DangDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University Nanning, P. R. China.
Gang ChenDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University Nanning, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article on p. 15632 in vol. 8, PMID: 26884832.].

Identifiers

PMID32509105
PMCPMC7270691

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.